Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2024 Jul:269:114-115.
doi: 10.1016/j.schres.2024.05.010. Epub 2024 May 18.

Efficacy of sodium nitroprusside in the treatment of drug-naive subjects in first episode psychosis - An open label study

Affiliations
Clinical Trial

Efficacy of sodium nitroprusside in the treatment of drug-naive subjects in first episode psychosis - An open label study

Marcelo P M Adelino et al. Schizophr Res. 2024 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Marcelo P. M. Adelino reports grants and personal fees from Janssen Pharmaceutical, Boehringer-Ingelheim, Novo Nordisk, Acadia Pharmaceutical, NeuromaTherapeutics, Cellavita, LiraNova, Parexel, IQVIA, Azidus, Synova, PPD, ICON. Marcel V. Nunes reports grants and personal fees from Janssen Pharmaceutical, Boehringer-Ingelheim, Novo Nordisk, Acadia Pharmaceutical, NeuromaTherapeutics, Cellavita, LiraNova, Parexel, IQVIA, Azidus, Synova, PPD, ICON. Marielle F. Q. Nunes reports grants and personal fees from Janssen Pharmaceutical, Eli Lilly, Novartis, Boehringer-Ingelheim, Novo Nordisk, Acadia Pharmaceutical, NeuromaTherapeutics, Cellavita, LiraNova, Parexel, IQVIA, Azidus, Synova, PPD, ICON. Lucas C. Quarantini reports consulting fees from Allergan, Abbot, Janssen Pharmaceutical, Libbs, Cristalia and Lundbeck and research fees from Janssen Pharmaceutical, CNPq. No others conflicts of interest declared concerning the publication of this article. Jaime C. E. Hallak is recipient of Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil) productivity fellowship (1A). Acioly L. T. Lacerda reports grants and personal fees from Janssen Pharmaceutical, Daiichi Sankyo, Cristalia Produtos Químicos e Farmacêuticos, Libbs, Apsen, Aché Laboratórios, Sanofi-Aventis, Novartis, Eli Lilly, H. Lundbeck A/S, Boehringer-Ingelheim, Novo Nordisk, Acadia Pharmaceutical, Neumora Therapeutics, Cellavita, LivaNova, EMS, Parexel, IQVIA, Azidus, Synova, PPD, Eurofarma, Abbott.

References

LinkOut - more resources